Finding 1081159 (2023-003)

Material Weakness
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2024-11-05
Audit: 327329
Organization: Inova Health System (VA)

AI Summary

  • Core Issue: There is a material weakness in internal controls over compliance related to procurement and vendor management for federal grants.
  • Impacted Requirements: The System failed to maintain necessary documentation for procurement methods and vendor evaluations, violating federal regulations under Title 2 U.S. Code of Federal Regulations.
  • Recommended Follow-Up: Update processes to ensure proper documentation is retained for procurement and vendor suspension and debarment compliance.

Finding Text

Federal Program Information Federal Agencies: Department of Health and Human Services (“HHS”) Pass-Through Entity: Virginia Department of Health Pass-Through Entity Number: Not Applicable Awards: Assistance Listing Number 93.918 – Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease (Part C) Award Periods: May 1, 2022 to April 30, 2023; May 1, 2023 to April 30, 2024 Description: Documentation of Procurement and Suspension and Debarment Type of Finding: Material Weakness in Internal Control Over Compliance Criteria In accordance with Title 2 U.S. Code of Federal Regulations, Part 200.303, Internal controls, “The Non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” Part 200.320 Methods of procurement to be followed states the following: “The non-Federal entity must have and use documented procurement procedures, consistent with the standards of this section and §§ 200.317, 200.318, and 200.319” regarding the methods of procurement used for the acquisition of property or services required under a Federal award or sub-award. Condition As part of our testing over the operating effectiveness of internal controls over the Procurement, Suspension and Debarment assertion, we noted that the System had a procurement policy that included procedures for small purchases (i.e. purchases between $50,000-$250,000) in which management obtains one or more sources from suppliers or public websites in order to document justification for vendor approval. However, records were not maintained to document the rationale for the procurement method, contract type selection, contractor selection or rejection, and the basis for the contract price. Management also validates that vendors are reviewed on a monthly basis to ensure they are not included on the suspension and debarment list. There was no documentation to support completeness and accuracy of the vendor list for suspension and debarment. Cause The System did not retain documentation to support compliance with the procurement policy that conforms to the provisions required by the Uniform Guidance. The System did not retain documentation to support the completeness and accuracy of the vendor list for suspension and debarment. Effect or potential effect Purchasing of goods and/or servicing with the grant funds may not be in compliance with the Uniform Guidance. The vendor list for suspension and debarment may not be complete and accurate and therefore, federal funds may be used to pay a contractor that is suspended or debarred. Questioned costs None. Identification of a repeat finding This is not a repeat finding. Context Small purchases were $106,345, which represents approximately 3% of total federal expenditures of $3,589,730 reported on the Schedule for the year ended December 31, 2023. Management subsequently documented the rationale for the procurement method, contract type selection, contractor selection or rejection, and the basis for the contract price. As part of our testing for suspension and debarment, we did not identify any vendors that were excluded from the suspension and debarment list that were part of the grant. Recommendation The System should update its process to ensure documentation is retained consistent with the procurement policy and suspension and debarment for purchasing goods and/or services with federal funds. View of responsible officials Management concurs with the finding and will implement procedures to documentation is retained to support procurement and suspension and debarment.

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring

Other Findings in this Audit

  • 504714 2023-001
    Material Weakness Repeat
  • 504715 2023-002
    Material Weakness
  • 504716 2023-002
    Material Weakness
  • 504717 2023-003
    Material Weakness
  • 1081156 2023-001
    Material Weakness Repeat
  • 1081157 2023-002
    Material Weakness
  • 1081158 2023-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $3.90M
12.750 Uniformed Services University Medical Research Projects $3.30M
93.917 Hiv Care Formula Grants $2.54M
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $808,634
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $688,909
93.939 Hiv Prevention Activities Non-Governmental Organization Based $620,250
93.350 National Center for Advancing Translational Sciences $395,461
20.RD Nhtsa Discretionary Safety Grants and Cooperative Agreements $348,454
93.RD Population Health Research Support $206,736
93.914 Hiv Emergency Relief Project Grants $203,144
93.767 Children's Health Insurance Program $167,129
93.145 Aids Education and Training Centers $163,492
16.575 Crime Victim Assistance $109,515
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $99,481
93.397 Cancer Centers Support Grants $85,635
12.420 Military Medical Research and Development $64,969
93.RD Nhlbi Pulmonary Vascular Program $63,860
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $50,621
93.RD Nhlbi Graft Sample and Data Collection Project $35,272
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $27,056
93.866 Aging Research $21,808
93.121 Oral Diseases and Disorders Research $14,209
93.865 Child Health and Human Development Extramural Research $9,722
93.940 Hiv Prevention Activities Health Department Based $8,652
21.027 Coronavirus State and Local Fiscal Recovery Funds $6,073
93.RD Support Services for the Lampoon Protocol Ide Enrollment Sites $5,716
93.103 Food and Drug Administration Research $1,199
93.837 Cardiovascular Diseases Research $687
93.838 Lung Diseases Research $549
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $528
93.RD Tactile and Ultrasound Imaging Fusion for Functional Assessment of the Female Pelvic Floor $157